IV lidocaine
Phase 3Small molecule
IV lidocaine is one of 111 small molecule programs targeting Tinnitus. It is currently in Phase 3.
4
Indications
12
Total Trials
4
Active Trials
110
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
84 competitors in Cesarean Section
#DrugCompanyPhaseTrials
1IV lidocaine
WWake Forest University Health Sciences
Phase 3
Fentanyl-Morphine
SSeoul National University Hospital
Phase 3
Ondansetron, Dexamethasone
KKing Khaled Eye Specialist Hospital
Phase 3
Acetaminophen/ibuprofen
SSeoul National University Hospital
Phase 3
Sebacoyl Dinalbuphine Ester
LLumosa Therapeutics Co., Ltd.
Phase 3
Morphine - .
RRambam Health Care Campus
Phase 3
Proamatine
TakedaPreclinical
Dynastat
PfizerPreclinical
Duragesic
CCephalon
Preclinical
Versed
CConrado Roberto Hoffmann Filho
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Liposomal Bupivacaine1 trial
Intravenous Lidocaine1 trial
Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Laparoscopy
Unknown status·—·N/A·NCT04506034·150 enrolled
7 more indications
Hemodynamic Response1 trial
Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation
Completed·—··NCT06107543·94 enrolled
Cesarean Section1 trial
Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section
Unknown status·—·N/A·NCT04505644·180 enrolled
Lidocaine Infusion1 trial
Intraoperative Lidocaine Infusion
Not yet recruiting·—·Phase 2/3·NCT07150481·90 enrolled
Endometriosis1 trial
Effects of Intravenous Lidocaine on Endometriosis Pain
Completed·—·N/A·NCT01968694·20 enrolled
Tinnitus1 trial
An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus
Recruiting·—·Phase 1·NCT04192773·40 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for IV lidocaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details